NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-010-2010-0-SE-21 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses SE EP 10798422.1 Issued
NICHD E-010-2010-0-FR-12 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses FR EP 10798422.1 Issued
NICHD E-010-2010-0-FI-11 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses FI EP 10798422.1 Issued
NICHD E-010-2010-0-DK-09 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses DK EP 10798422.1 Issued
NICHD E-010-2010-0-IS-16 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses IS EP 10798422.1 Issued
NICHD E-010-2010-0-IE-15 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses IE EP 10798422.1 Issued
NICHD E-010-2010-0-GR-14 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses GR EP 10798422.1 Issued
NICHD E-010-2010-0-DE-08 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses DE EP 10798422.1 Issued
NICHD E-010-2010-0-BE-06 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses BE EP 10798422.1 Issued
NICHD E-010-2010-0-NL-18 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses NL EP 10798422.1 Issued
NICHD E-010-2010-0-NO-19 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses NO EP 10798422.1 Issued
NICHD E-010-2010-0-PT-20 Method For The Detecting Hematoma, Portable Detection And Discrimination Device And Related Systems And Apparatuses PT EP 10798422.1 Issued
NICHD E-010-2010-0-PCT-02 Method For The Detecting Hematoma,Portable Detection And Discrimination Device And Related Systems And Apparatuses PCT PCT PCT/US2010/060506 Expired
NCATS E-268-2009-0-PCT-02 DELIVERY OF TRANSTHYRETIN ACROSS THE BLOOD-BRAIN BARRIER AS A TREATMENT FOR ALZHEIMER'S DISEASE. PCT PCT PCT/US2010/060205 Expired
NCI E-021-2011-0-US-01 Synthetic Peptide Inhibitors Of Wnt Pathway US 61/422,857 Abandoned
NIAID E-043-2011-0-US-01 Adenovirus Serotype 26 and Serotype 35 Filovirus Vaccine US 61/422,954 Abandoned
NCI E-312-2005-0-US-04 Immunogenic Peptides and Methods of Use For Treating And Preventing Cancer US DIV 12/966,341 8614304 Abandoned PDF
NIDCR E-160-2000-1-US-06 T2R, A NOVEL FAMILY OF TASTE RECEPTORS US CON 12/966,955 8329885 Expired PDF
NINDS E-014-2006-2-US-08 In-vitro Assay To Screen For Enhancement Of Mutated Alpha-galactosidase A (GLA) By Small Molecules Chaperones For Fabry Disease US National Stage 12/966,904 Abandoned
NCI E-045-2011-0-US-01 CD22 Antibodies With Improved Binding Affinity US 61/421,472 Abandoned
NIAID E-055-2007-3-US-03 Use of Antagonists Of The Interaction Between HIV Gp120 And A4B7 Integrin US National Stage 12/518,035 9193790 Issued PDF
NCATS E-257-2010-0-US-01 Substituted Pyrazolopyrimidines As Glucocerebrosidase Activators US 61/420,946 Abandoned
NCI E-069-2010-0-US-01 Modulating Immune Cell Activity Using Cylokine-induced Src Homology 2 And/Or High Temperature Requirement A-1 US 61/420,825 Abandoned
NCI E-026-2011-0-US-01 Diagnosis And Treatment Of Adrenocortical Tumors Using Human MicroRNA-483 US ORD 12/961,298 9150926 Abandoned PDF
NCI E-257-2008-0-US-32 Melanoma Associated Peptide Analogues And Vaccines Against Melanoma US DIV 12/961,217 8075900 Abandoned PDF
NCI E-256-2008-0-US-05 Survival Predictor For Diffuse Large B Cell Lymphoma US National Stage 12/996,489 Abandoned
NCI E-020-2011-0-US-01 Layered Electrophoretic Transfer US 61/420,258 Abandoned
NCI E-294-2010-0-US-01 Allele Specific ShRNAs For Nanog, Pharmaceutical Composition Comprising The SHRNA, And Its Method of Use to Treat Cancer US 61/420,214 Abandoned
NICHD E-239-2012-0-PCT-02 METHOD FOR LATE POST COITAL CONTRACEPTION USING ULIPRISTAL ACETATE PCT PCT PCT/EP2010/068863 Expired
NHLBI E-291-2009-0-PCT-02 Hydrazone And Diacyl Hydrazine Compunds And Methods Of Use PCT PCT PCT/US2010/058849 Expired
NCI E-200-2011-1-US-01 METHODS OF TREATING LYMPHOCYTIC LEUKEMIA USING INHIBITORS OF BRUTON'S TYROSINE KINASE US 61/419,764 Abandoned
NCI E-076-2013-0-US-01 HUMAN BISPECIFIC T-CELL ENGAGER MOLECULES AND METHODS OF USE US 61/419,347 Abandoned
NCI E-124-2011-0-US-01 Anti-podoplanin Antibodies And Methods Of Use US 61/419,327 Abandoned
NCI E-125-2011-1-US-01 Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use US 61/419,317 Abandoned
NIDDK E-049-2010-2-PCT-01 Methanocarba Adenosine Derivatives And Their Dendrimer Conjugates Thereof PCT PCT COMB PCT/US2010/058746 Expired
NIDDK E-049-2010-2-EP-02 Methanocarba Adenosine Derivatives And Dendrimer Conjugates Thereof EP National Stage 10788201.1 Abandoned
NCI E-039-2011-0-US-01 Chimeric Rabbit/human ROR1 Antibodies US 61/418,550 Abandoned
NIAID E-268-2010-0-US-01 Treatment of Inflammatory Diseases by Targeting the Adaptor Protein CIKS US 61/418,782 Abandoned
NIMH E-043-1997-2-US-11 Methods For Expression and Purification Of Immunotoxins US DIV 12/957,165 8921097 Issued PDF
NHLBI E-292-2009-0-PCT-02 Signal-to-noise Enhancement Imaging Applications Using a Time Series Of Images PCT PCT PCT/US2010/058301 Expired
NCI E-133-2009-0-PCT-02 Nitroxide Therapy For The Treatment Of Von-Hippel-Lindau Disease (VHL) And Renal Clear Cell Carcinoma (RCC) PCT PCT PCT/US2010/058332 Expired
NHLBI E-047-2009-0-PCT-02 Synthetic ApoA-1 Mimetic Amphipathic Peptides And Methods of Use Thereof PCT PCT PCT/US2010/058230 Expired
NCI E-259-2008-0-US-03 A Method For Identifying Patients At Risk For Developing Her-2+ Breast Cancer Brain Metastases, Based On Molecular Characteristics Of The Formalin Fixed, Paraffin Embedded (FFPE) Primary Tumor US National Stage 12/955,217 Abandoned
NIAMS E-216-2010-0-AU-02 Compositions and Methods for Treating or Preventing Lupus AU National Stage 2010364324 Issued
NIAMS E-216-2010-0-PCT-01 Compositions and Methods for Treating and Preventing Lupus PCT PCT PCT/US2010/058077 Expired
NIA E-019-2011-0-US-01 Compositions and Methods for Treating Neoplasia US 61/416,619 Abandoned
CC E-228-2009-0-US-09 System And Method Of Integrated Biopsy And Therapy US National Stage 13/321,836 1098-05-08 Issued PDF
NCI E-125-2011-0-US-01 Antibodies And Immunotoxins Reactive With Human Gangliosides 3'6'iso-LM1 And 3'6'iso-LD1 And Methods Of Use US 61/416,096 Abandoned
NCI E-182-2008-0-US-04 Method of Treating Pneumoconiosis With Oligodeoxynecleotides US National Stage 12/993,809 8222225 Abandoned PDF
NCI E-273-2002-0-US-03 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE US CON 12/949,533 Abandoned